RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
5.95
-0.05 (-0.83%)
At close: May 19, 2026, 4:00 PM EDT
5.77
-0.18 (-3.07%)
After-hours: May 19, 2026, 6:33 PM EDT
RxSight Market Cap
RxSight has a market cap or net worth of $246.31 million as of May 19, 2026. Its market cap has decreased by -61.74% in one year.
Market Cap
246.31M
Enterprise Value
42.57M
1-Year Change
-61.74%
Ranking
Category
Stock Price
$5.95
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has decreased from $424.33M to $246.31M, a decrease of -41.95%. That is a compound annual growth rate of -10.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 248.38M | -42.03% |
| Dec 31, 2025 | 428.44M | -69.08% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
| Jul 30, 2021 | 424.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CapsoVision | 332.26M |
| Electromed | 322.59M |
| Senseonics Holdings | 291.29M |
| Sight Sciences | 261.71M |
| 908 Devices | 253.73M |
| Profound Medical | 251.11M |
| TriSalus Life Sciences | 196.53M |
| InfuSystem Holdings | 195.38M |